ORC(ORC)
ORC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $137M | $398M |
| Low | $121M | $376M |
| High | $154M | $421M |
| EBITDA Avg | $55M | $159M |
| Low | $49M | $150M |
| High | $62M | $168M |
| EBIT Avg | $55M | $159M |
| Low | $49M | $150M |
| High | $62M | $168M |
| Net Income Avg | $151M | $176M |
| Low | $136M | $172M |
| High | $167M | $181M |
| EPS Avg | $1.18 | $1.38 |
| Low | $1.06 | $1.34 |
| High | $1.30 | $1.41 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $35M | $38M | $161M | $162M | $163M | $164M |
| Low | $32M | $34M | $144M | $144M | $145M | $146M |
| High | $41M | $44M | $186M | $186M | $187M | $188M |
| EBITDA Avg | $14M | $15M | $65M | $65M | $65M | $66M |
| Low | $13M | $14M | $57M | $58M | $58M | $58M |
| High | $16M | $17M | $74M | $75M | $75M | $75M |
| EBIT Avg | $14M | $15M | $65M | $65M | $65M | $66M |
| Low | $13M | $14M | $57M | $58M | $58M | $58M |
| High | $16M | $17M | $74M | $75M | $75M | $75M |
| Net Income Avg | $56M | $59M | $69M | $65M | $63M | $61M |
| Low | $48M | $51M | $59M | $56M | $54M | $52M |
| High | $67M | $71M | $83M | $78M | $76M | $72M |
| EPS Avg | $0.30 | $0.31 | $0.36 | $0.34 | $0.34 | $0.32 |
| Low | $0.25 | $0.27 | $0.31 | $0.30 | $0.29 | $0.27 |
| High | $0.35 | $0.37 | $0.44 | $0.41 | $0.40 | $0.38 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |